Form 4: Director Juan Jose Chacon Quiros Sells ESTA Shares

Director Juan Jose Chacon Quiros sold 75,000 shares of Establishment Labs Holdings Inc. via a Rule 10b5-1 trading plan.

Summary

• Director Juan Jose Chacon Quiros executed a series of sales of Establishment Labs Holdings Inc. (ESTA) common shares between April 23, 2026, and April 27, 2026.
• A total of 75,000 shares were sold across multiple transactions.
• The sales were conducted pursuant to a pre-established Rule 10b5-1 trading plan.
• The shares were held indirectly through Sariel Group Ltd., where the reporting person maintains voting and dispositive power.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sales were conducted through a pre-planned 10b5-1 arrangement, which is standard practice for executives.

Positives

• The sales were executed under a pre-arranged Rule 10b5-1 trading plan, which is a standard mechanism for insiders to sell shares without triggering concerns regarding non-public information.

Negatives

• The transaction represents a significant reduction in the reporting person's indirect beneficial ownership of company stock.

Risks

• Insider selling can sometimes be perceived by the market as a lack of confidence in the short-term growth prospects of the company.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a routine corporate governance practice and generally does not signal a change in fundamental business strategy or outlook.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate insiders to manage personal liquidity while maintaining compliance with SEC regulations.

Related Party Transactions

• The shares sold were held by Sariel Group Ltd., an entity in which the reporting person is a shareholder with voting and dispositive power.

Stakeholder Impact

• Shareholders should note the reduction in insider holdings, though the use of a 10b5-1 plan mitigates concerns regarding insider sentiment.

Next Steps

• No future actions or milestones were disclosed in this filing.

Key Dates

Keywords

ESTA, Establishment Labs, Insider Trading, Form 4, Equity, Director